Sage Therapeutics, Inc.

Home » Sage Therapeutics, Inc.

Secondary

Sage Therapeutics, Inc.

Sage Therapeutics is a clinical-stage biopharmaceutical company committed to developing novel medicines to transform the lives of patients with life-altering central nervous system (CNS) disorders.

Symbol

SAGE

Last Closing Price
$88.25

Shares
3,000,000

Effective Date
November 15, 2017

Underwriters
J.P. Morgan, Goldman Sachs, Morgan Stanley

To view the prospectus for Sage Therapeutics, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253